Hannah Leitch, MD
Critical Care Medicine · Reno, NVNPI 1740739580
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (41.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Intuitive Surgical at 56.0% of the total. Reporting peaked in 2022 at $5,164 and has fallen 74.9% since, to $1,295 in 2025. Among critical care medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 44 payments — averaging $171.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Medical Device Business Services, Inc.$980
- Boston Scientific$775
- Actelion Pharmaceuticals US, Inc.$301
- GSK$217
- AstraZeneca$216
- plus $823 from 10 others
What the payments were for
- Travel & lodging$2,89138%
- Food & beverage$1,53720%
- Education$3,09941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $4,214 |
| Medical Device Business Services, Inc. | 4 | $980 |
| Boston Scientific | 6 | $775 |
| Actelion Pharmaceuticals US, Inc. | 4 | $301 |
| GSK | 9 | $217 |
| AstraZeneca | 3 | $216 |
| Cook Medical LLC | 1 | $182 |
| Siemens Medical Solutions USA, Inc. | 1 | $125 |
| Vapotherm Inc | 1 | $114 |
| Regeneron Healthcare Solutions, Inc. | 1 | $103 |
| Boehringer Ingelheim | 1 | $85 |
| E.r. Squibb & Sons, L.L.C. | 1 | $81 |
| Insmed, Inc. | 1 | $53 |
| ZOLL Respicardia, Inc. | 1 | $31 |
| ERBE USA Inc | 1 | $30 |
| Philips North America LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Da Vinci Surgical System$1,071
- MONARCH$947
- GENERAL PULMONARY$602
- Blue Rhino$182
- Cios Spin$125
- BREZTRI$120
- Precision Flow$114
- UPTRAVI$114
- OPSUMIT$114
How this compares
$7,527 in reported general payments places this provider in the 95th percentile of 68 critical care medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 17 | $211,037 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 89 | $63,693 |
| Breo ElliptaFluticasone/Vilanterol | 59 | $24,053 |
| Wixela InhubFluticasone Propion/Salmeterol | 63 | $8,874 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $3,655 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $1,498 |
| Ventolin HfaAlbuterol Sulfate | 16 | $1,456 |
| Montelukast Sodium | 19 | $252 |
| Fluticasone Propionate | 14 | $111 |
| Omeprazole | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev | $85 | $211,03717 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $217 | $87,746148 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 68 critical care medicine providers in Nevada.
Other critical care medicine in Reno
- Farah Madhani-LovelyReno$15K
- Jeffrey BaconReno$5K
- Fernando FuentesReno$4K
- Faisal SiddiquiReno$2K
- Joshua BiglerReno$674
- Rudy TedjaReno$587
- Jeremy GondaReno$531
- Jason BlockReno$462
- Joshua JewellReno$399
- Richard MaierReno$312
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.